Pricing Log in Create free account

Solid Biosciences Inc. (SLDB) vs Zevra Therapeutics, Inc. (ZVRA)

Solid Biosciences Inc. and Zevra Therapeutics, Inc. are both Biotechnology companies. Solid Biosciences Inc. and Zevra Therapeutics, Inc. are of similar size ($615.5M and $609.9M). Solid Biosciences Inc. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 10.5×. Zevra Therapeutics, Inc. has the higher net margin (42.3% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Zevra Therapeutics, Inc. leads on 11 and Solid Biosciences Inc. on 3.

Valuation

Metric SLDB ZVRA Biotechnology median
P/E n/m 10.47 8.50
P/S 70.64 4.33 9.71
P/B 2.12 2.70 2.13
Price to free cash flow n/m 17.80 20.82
EV/EBITDA n/m 5.79 0.64
EV/Sales 37.04 3.43 9.21
Earnings yield (34.54%) 9.55% (33.15%)
Free cash flow yield (23.62%) 5.62% (25.50%)

Profitability

Metric SLDB ZVRA Biotechnology median
Gross margin 0.00% 95.46% 65.16%
Operating margin 0.00% 60.54% 0.00%
Net margin 0.00% 42.25% 0.00%
Free cash flow margin 0.00% 24.30% 0.00%
Return on equity (65.50%) 34.33% (56.36%)
Return on assets (56.83%) 20.57% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SLDB ZVRA Biotechnology median
Revenue growth (TTM) — 119.40% 6.02%
EPS growth (last fiscal year) 34.97% 159.21% 30.26%
Revenue growth, 5-year CAGR — 51.62% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SLDB ZVRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.82 5.17 4.72
Net debt to EBITDA 1.05 39.03 0.96

Dividend

Metric SLDB ZVRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SLDB ZVRA Biotechnology median
Market cap 615.48m 609.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack